These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 12461330

  • 1. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 2. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J.
    Cancer Res; 2000 Jul 01; 60(13):3599-604. PubMed ID: 10910074
    [Abstract] [Full Text] [Related]

  • 3. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH.
    Clin Cancer Res; 2004 Jun 01; 10(11):3614-20. PubMed ID: 15173067
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jun 01; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 5. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D.
    N Engl J Med; 1995 Feb 16; 332(7):429-35. PubMed ID: 7619114
    [Abstract] [Full Text] [Related]

  • 6. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
    Nathan CO, Liu L, Li BD, Abreo FW, Nandy I, De Benedetti A.
    Oncogene; 1997 Jul 31; 15(5):579-84. PubMed ID: 9247311
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, Brentani MM.
    Cancer Detect Prev; 2004 Jul 31; 28(3):178-86. PubMed ID: 15225897
    [Abstract] [Full Text] [Related]

  • 8. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM, Bentzen SM, Daley FM, Dische S, Saunders MI, Richman PI, Wilson GD.
    Clin Cancer Res; 2004 Jun 01; 10(11):3745-54. PubMed ID: 15173081
    [Abstract] [Full Text] [Related]

  • 9. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J.
    Clin Cancer Res; 2004 Sep 01; 10(17):5820-7. PubMed ID: 15355912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.
    J Pathol; 2002 Dec 01; 198(4):476-86. PubMed ID: 12434417
    [Abstract] [Full Text] [Related]

  • 12. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
    Temam S, Casiraghi O, Lahaye JB, Bosq J, Zhou X, Julieron M, Mamelle G, Lee JJ, Mao L, Luboinski B, Benard J, Janot F.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4022-8. PubMed ID: 15217934
    [Abstract] [Full Text] [Related]

  • 13. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A, Cutrona D, Palmeri S, Maiolino L, Puzzo L, Allegra E.
    Acta Otorhinolaryngol Ital; 1999 Dec 15; 19(6):342-7. PubMed ID: 10875157
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R, Geng J, Wang JH, Chu XY, Geng HC, Chen LB.
    Lung Cancer; 2009 Nov 15; 66(2):237-44. PubMed ID: 19261348
    [Abstract] [Full Text] [Related]

  • 15. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
    Laryngoscope; 2004 Dec 15; 114(12):2063-72. PubMed ID: 15564824
    [Abstract] [Full Text] [Related]

  • 16. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 15; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX.
    Clin Cancer Res; 2001 Feb 15; 7(2):290-6. PubMed ID: 11234882
    [Abstract] [Full Text] [Related]

  • 18. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.
    Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL, Meschonat C, Black D, Li BD.
    J Surg Res; 1999 Jul 01; 85(1):37-42. PubMed ID: 10383835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.